What is one of the long-acting bronchodilators for patients with COPD or chronic bronchiectasis?

Salmeterol is a long-acting beta-2 adrenergic agonist (LABA) that is specifically indicated for the management of chronic obstructive pulmonary disease (COPD) and chronic bronchiectasis. It works by relaxing the muscles of the airways, leading to prolonged bronchodilation, which helps improve airflow and reduce symptoms. This extended duration of action makes it suitable for once or twice daily dosing, which is beneficial for patients needing long-term management of their respiratory conditions.

In the context of managing COPD, salmeterol can help in controlling persistent symptoms and reducing exacerbations, thus improving the overall quality of life for patients. Its role as a long-acting agent distinguishes it from other bronchodilators that might be used for immediate relief rather than ongoing control.

Other options listed include medications like ipratropium, which is a short-acting anticholinergic, and budesonide, a corticosteroid that is also not a bronchodilator. Levalbuterol, a short-acting beta-agonist, is used for quick relief of asthma or COPD symptoms. However, they do not have the long-acting properties necessary for chronic management, making salmeterol the appropriate choice for patients with the specified